Home / Blog / 2021 Cholangiocarcinoma Foundation’s Annual Conference

ac-2021-logo

We are pleased to announce that the 8th Annual Cholangiocarcinoma Foundation Conference will be held virtually March 31st- April 2nd, 2021. John Bridgewater, MD, PhD of the UCL Cancer Institute, London and Funda Meric-Bernstram, MD of MD Anderson Cancer Center will Co-Chair the event.

Dr. Bridgewater specializes in gastrointestinal oncology, with a particular interest in biliary tract cancers and carcinomas of unknown primary origin. He leads the National Cancer Research Institute subgroup in biliary tract malignancy and is actively involved in the research portfolio.

Dr. Meric-Bernstam is the Chair of the Department of Investigational Cancer Therapeutics -- the Phase I Program as well as the Medical Director of the Institute for Personalized Cancer Therapy (IPCT) at MD Anderson Cancer Center. Her clinical research is focused on Phase I /II trials with a focus on novel mechanisms of action, novel combination therapies, and biomarkers to predict and monitor drug response.

This event continues to be the premier source for the presentation of cutting-edge research, innovative therapies, and patient education in the field of cholangiocarcinoma and is always the highlight of our year. More than 700 Patients & Caregivers, 300 Clinicians and Researchers, and 400 Industry representatives and sponsors hailing from 49 states and 42 countries participated in the 2020 Annual Conference.

Please visit our 2021 landing page for more information and to signup for updates.

john-sq

John Bridgewater, MD, PhD

UCL CANCER INSTITUTE

London, UK

funda-sq

Funda Meric-Bernstram, MD

MD ANDERSON CANCER CENTER

HOUSTON, TX

Home / Blog / 2021 Cholangiocarcinoma Foundation’s Annual Conference